Analysts
Scores, price targets and rating changes published by the firms we track. Informational, not advice.
Price target forecast
The average analyst target through the past year, and where analysts see the price a year from now.
Nov 6, 20260 analyst targets · 90 days
- Share price
- $2.10
- Average 1Y price target
- $4.25+102.38%
- Agreement
- Low
Analysts agreement range is spread more than 30% from the average
Share priceAverage analyst target (90-day window), shaded 10th–90th percentile12-month range from the lowest to the highest current target, dashed to the average
Rating scores
Each factor is scored 1 (weak) to 5 (strong).
- Overall2
- DCF5
- Return on equity1
- Return on assets1
- Debt / equity1
- P/E1
- P/B4
Average price target
Mean of the targets analysts published in each window.
| Window | Targets | Average |
|---|---|---|
| Last month | 0 | — |
| Last quarter | 3 | $4.17 |
| Last year | 10 | $4.25 |
| All time | 24 | $17.06 |
Recent rating changes
The latest 40 changes by research firm, newest first.
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 5, 2026 | BMO Capital | maintain | Outperform | Outperform |
| Sep 23, 2026 | Morgan Stanley | maintain | Underweight | Underweight |
| Aug 14, 2026 | UBS | maintain | Neutral | Neutral |
| May 18, 2026 | BMO Capital | maintain | Outperform | Outperform |
| May 18, 2026 | Barclays | maintain | Underweight | Underweight |
| May 15, 2026 | UBS | maintain | Neutral | Neutral |
| May 15, 2026 | Baird | maintain | Neutral | Neutral |
| Mar 16, 2026 | Goldman Sachs | maintain | Neutral | Neutral |
| Mar 16, 2026 | BMO Capital | maintain | Outperform | Outperform |
| Mar 16, 2026 | Barclays | downgrade | Equal Weight | Underweight |
| Mar 13, 2026 | UBS | maintain | Neutral | Neutral |
| Mar 13, 2026 | Morgan Stanley | downgrade | Equal Weight | Underweight |
| Mar 13, 2026 | Baird | downgrade | Outperform | Neutral |
| Nov 13, 2025 | UBS | downgrade | Buy | Neutral |
| Nov 13, 2025 | Morgan Stanley | downgrade | Overweight | Equal Weight |
| Nov 13, 2025 | BMO Capital | maintain | Outperform | Outperform |
| Nov 13, 2025 | Barclays | maintain | Equal Weight | Equal Weight |
| Nov 13, 2025 | Baird | maintain | Outperform | Outperform |
| Oct 24, 2025 | Morgan Stanley | maintain | Overweight | Overweight |
| Oct 15, 2025 | Goldman Sachs | downgrade | Buy | Neutral |
| Oct 10, 2025 | UBS | maintain | Buy | Buy |
| Aug 14, 2025 | UBS | maintain | Buy | Buy |
| Aug 13, 2025 | Morgan Stanley | maintain | Overweight | Overweight |
| Aug 13, 2025 | JP Morgan | downgrade | Overweight | Neutral |
| Aug 13, 2025 | Goldman Sachs | maintain | Buy | Buy |
| Aug 13, 2025 | BMO Capital | maintain | Outperform | Outperform |
| Aug 13, 2025 | Barclays | downgrade | Overweight | Equal Weight |
| Aug 13, 2025 | Baird | maintain | Outperform | Outperform |
| Jul 28, 2025 | Morgan Stanley | maintain | Overweight | Overweight |
| Jun 11, 2025 | Goldman Sachs | maintain | Buy | Buy |
| May 15, 2025 | BMO Capital | maintain | Outperform | Outperform |
| May 14, 2025 | Morgan Stanley | maintain | Overweight | Overweight |
| May 14, 2025 | Goldman Sachs | maintain | Buy | Buy |
| May 14, 2025 | Baird | maintain | Outperform | Outperform |
| Apr 15, 2025 | UBS | maintain | Buy | Buy |
| Mar 24, 2025 | BMO Capital | maintain | Outperform | Outperform |
| Mar 21, 2025 | UBS | maintain | Buy | Buy |
| Mar 21, 2025 | Morgan Stanley | maintain | Overweight | Overweight |
| Mar 21, 2025 | Goldman Sachs | maintain | Buy | Buy |
| Mar 21, 2025 | Baird | maintain | Outperform | Outperform |